Funder: National Institutes of Health
Due Dates: April 4, 2025 (Revision/Resubmission) | October 3, 2025 (Revision/Resubmission) | Letters of Intent: March 5, 2025 & September 3, 2025 (30 days prior)
Funding Amounts: Up to $150,000 direct costs/year for up to 2 years, not to exceed the parent R01’s remaining project period.
Summary: Supports revision applications to active NCI R01s to incorporate novel NCI IMAT-supported technologies that accelerate or expand cancer research.
Key Information: Only currently funded NCI R01s are eligible; technology must be developed via the NCI IMAT program and not by the parent R01 PI.